Join
Live feed
·
INSIDERFilingvia Quantisnow
Zynerba Pharmaceuticals Inc. logo

Jones Kenneth T was granted 30,000 shares, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
ZYNE· Zynerba Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track ZYNE (Zynerba Pharmaceuticals Inc.) and more on Quantisnow.